Forest Laboratories
3
78M
3
0.04
3
1
- Areas of investment
Summary
Forest Laboratories appeared to be the Corporate Investor, which was created in 1954. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the New York.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the Forest Laboratories, startups are often financed by Polaris Partners, New Enterprise Associates, HealthCare Ventures.
We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight moksha8 Pharmaceuticals, TransTech Pharma, Trevena. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
This Forest Laboratories works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this Corporate Investor is 80 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2010.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.04
- Investments by industry
- Biotechnology (3)
- Pharmaceutical (3)
- Health Care (2)
- Biopharma (1)
- Medical Device (1)
- Investments by region
-
- United States (3)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Trevena | 09 May 2013 | Biotechnology, Health Care, Pharmaceutical, Biopharma | Late Stage Venture | 60M | United States, Pennsylvania, Upper Merion Township |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.